NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

BACKGROUND: Cognitive deficits both prior to therapy and during treatment have been documented within the glioblastoma (GBM) population. As more effective therapies arise, the options to explore lasting cognitive effects broaden. Based on pre-clinical data demonstrating synergism with radiation (RT)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Loughan, Ashlee, Shafer, Danielle, Lanoye, Autumn, Braun, Sarah, Dent, Paul, Malkin, Mark
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693109/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.579
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia